Skip to main content
Log in

Oxytocin inhibits proliferation of human breast cancer cell lines

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

In this study we show that treatment of MDA-MB231 hormone-independent human breast cancer cells with oxytocin (OT) or with the OT analogue F314 induces significant growth inhibition together with a change in cell phenotype. In MCF7 and T47D human breast cancer cells, OT inhibits oestrogen-induced cell growth. In these same cells, OT administration significantly enhances the inhibitory effect of tamoxifen on cell proliferation. MDA-MB231, MCF7 and T47D cells all express mRNA specific for the OT receptor. These data suggest that it may be possible to inhibit breast cancer growth using OT and OT analogues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Böcker W, Bier B, Freytag G, Brommelkamp B, Jarash ED, Edel G, Dockhorn-Dworniczak B, Schmidt KW (1992) An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. I. Normal breast and benign proliferative lesions. Virchows Arch [A] 421:315–322

    Google Scholar 

  2. Böcker W, Bier B, Freytag G, Brommelkamp B, Jarash ED, Edel G, Dockhorn-Dworniczak B, Schmidt KW (1992) An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. II. Epitheliosis and ductal carcinoma in situ. Virchows Arch [A] 421:323–330

    Google Scholar 

  3. Bodwin JS, Clair T, Cho-Chung YS (1978) Inverse relation between estrogen receptors and cyclic adenosine 3′,5′-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3′:5′-monophosphate treatment or ovariectomy. Cancer Res 38:3410–3413

    Google Scholar 

  4. Cailleau R, Young R, Olive' M, Reeves WJ (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53:661–674

    Google Scholar 

  5. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-PhOH-chloroform extraction. Anal Biochem 162:156–159

    Article  CAS  PubMed  Google Scholar 

  6. Cook SJ, McCormick F (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069–1072

    Google Scholar 

  7. Katsaros D, Ally S, Cho-Chung YS (1988) Site-selective cyclic AMP analogues are antagonistic to estrogen stimulation of growth and proto-oncogene expression in human breast cancer cells. Int J Cancer 41:863–867

    Google Scholar 

  8. Keydar I, Chen L, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15:659–670

    Google Scholar 

  9. Melin P, Vilhardt H, Lindeberg G, Larsson LE, Akerlund M (1981) Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity. J Endocrinol 88:173–180

    Google Scholar 

  10. Aurell CJ, Johansson E, Persson R, Berdén L, Nilsson A, Trojnar J, Abbe M, Ekholm K, Hansson C, Nylen A, Rosenquist A, Johansson B, Persson C, Melin P (1993) Synthesis and pharmacological properties of some Carba-6 and Carba-1 oxytocin antagonists. In: Schneider CH, Eberle AN (eds) Peptides 1992, ESCOM Science Publishers, Leiden, pp 697–699

    Google Scholar 

  11. Olins GM, Bremel RD (1984) Oxytocin stimulated myosin phosphorylation in mammary myoepithelial cells: roles of calcium ions and cyclic nucleotides. Endocrinology 114:1617–1626

    Google Scholar 

  12. Reed KC, Manor DA (1985) Rapid transfer of DNA from agarose gel to nylon membranes. Nucleic Acids Res 13:7207–7221

    Google Scholar 

  13. Russo J, Russo IH (1980) Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40:2677–2681

    Google Scholar 

  14. Sala NL, Freire F (1974) Relationship between ultrastructure and response to oxytocin of the mammary myoepithelium throughout pregnancy and lactation: effect of estrogen and progesterone. Biol Reprod 11:7–17

    Google Scholar 

  15. Sapino A, Pietribiasi F, Bussolati G, Marchisio PC (1986) Estrogen- and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 Cells. Cancer Res 46:2526–2531

    Google Scholar 

  16. Sapino A, Macri' L, Gugliotta P, Bussolati G (1990) Immunocytochemical identification of proliferating cell types in mouse mammary gland. J Histochem Cytochem 38:1541–1547

    Google Scholar 

  17. Sapino A, Papotti M, Sanfilippo B, Gugliotta P, Bussolati G (1992) Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma. Cancer Res 52:1553–1560

    Google Scholar 

  18. Sapino A, Macri' L, Tonda L, Bussolati G (1993) Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland. Endocrinology 133:838–842

    Google Scholar 

  19. Sapino A, Macri' L, Gugliotta P, Pacchioni D, Liu YJ, Medina D, Bussolati G (1993) Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation 55:13–18

    Google Scholar 

  20. Soloff MS (1979) Regulation of oxytocin action at the receptor level (minireview). Life Sci 25:1453–1459

    Google Scholar 

  21. Sonnenberg A, Daams J, Van derValk MA, Hilkens J, Hilgers J (1990) Development of the mouse mammary gland. Identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. J Histochem Cytochem 34:1036–1046

    Google Scholar 

  22. Soule HD, Vazquez J, Long A, Albert S, Brennan M (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409–1416

    Google Scholar 

  23. Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, Rubalcava B, Parandoosh Z, Chang Y, Revankar GR, Crabtree GW, Robins RK, Cho-Chung YS (1988) Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res 48:1642–1650

    Google Scholar 

  24. Takemura M, Nomura S, Kimura T, Inoue T, Onoue H, Azuma C, Saji F, Kitamura Y, Tanizawa O (1993) Expression and localization of oxytocin receptor gene in human uterine endometrium in relation to the menstrual cycle. Endocrinology 132:1830–1835

    Google Scholar 

  25. Taylor AH, Ang VTY, Jenkins JS, Silverlight JJ, Coombes RC, Luqmani YA (1990) Interaction of vasopressin and oxytocin with human breast carcinoma cells. Cancer Res 50:7882–7886

    Google Scholar 

  26. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065–1068

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cassoni, P., Sapino, A., Negro, F. et al. Oxytocin inhibits proliferation of human breast cancer cell lines. Vichows Archiv A Pathol Anat 425, 467–472 (1994). https://doi.org/10.1007/BF00197549

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00197549

Key words

Navigation